vimarsana.com

Latest Breaking News On - Data access request service - Page 1 : vimarsana.com

Health outcomes after myocardial infarction: A population study of 56 million people in England

Using hospital records of 34 million adults admitted to hospitals in England, Marlous Hall and team examine the long-term risk of major health outcomes following myocardial infarction.

United-kingdom
United-states
South-africa
Boston
Massachusetts
Northern-ireland
Craigavon
Scotland
British
Andrep-kengne
Charlotte-sturley
Daiichi-sankyo

Mortality rates among patients successfully treated for hepatitis C in the era of interferon-free antivirals: population based cohort study

Objectives To quantify mortality rates for patients successfully treated for hepatitis C in the era of interferon-free, direct acting antivirals and compare these rates with those of the general population. Design Population based cohort study. Setting British Columbia, Scotland, and England (England cohort consists of patients with cirrhosis only). Participants 21 790 people who were successfully treated for hepatitis C in the era of interferon-free antivirals (2014-19). Participants were divided into three liver disease severity groups: people without cirrhosis (pre-cirrhosis), those with compensated cirrhosis, and those with end stage liver disease. Follow-up started 12 weeks after antiviral treatment completion and ended on date of death or 31 December 2019. Main outcome measures Crude and age-sex standardised mortality rates, and standardised mortality ratio comparing the number of deaths with that of the general population, adjusting for age, sex, and year. Poisson regressi

United-kingdom
Midlands
Leicestershire
Scotland
British
William-irving
Novartis
Data-access-request-service
Midlands-research-ethics-committee
Analysis-service
Research-foundation
National-cancer-registration

Outcome of COVID-19 in hospitalised immunocompromised patients: An analysis of the WHO ISARIC CCP-UK prospective cohort study

Using data from the WHO ISARIC CCP-UK cohort, Dr. Lance Turtle and colleagues report on the outcome of COVID-19 in immunocompromised patients that are hospitalised.

United-kingdom
Glasgow
Glasgow-city
London
City-of
Scotland
Oxford-immunotech
Daiichi-sankyo
Chiesi-farmaceutici
Eli-lilly
Digital-data-access-request-service
Scotlanda-research-ethics-committee-ref

Report urges more data sharing between NHS and private healthcare

Report urges more data sharing between NHS and private healthcare
ukauthority.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ukauthority.com Daily Mail and Mail on Sunday newspapers.

James-austin
Jon-fistein
Ian-paterson
Data-alignment-programme
Digital-data-access-request-service
Healthcare-information-network
Acute-data-alignment-programme
Private-healthcare-information-network
Data-access-request-service
Social-care-jeremy-hunt

Predicting major complications in patients undergoing laparoscopic and open hysterectomy for benign indications

Background: Hysterectomy, the most common gynecological operation, requires surgeons to counsel women about their operative risks. We aimed to develop and validate multivariable logistic regression models to predict major complications of laparoscopic or abdominal hysterectomy for benign conditions. Methods: We obtained routinely collected health administrative data from the English National Health Service (NHS) from 2011 to 2018. We defined major complications based on core outcomes for postoperative complications including ureteric, gastrointestinal and vascular injury, and wound complications. We specified 11 predictors a priori. We used internal–external cross-validation to evaluate discrimination and calibration across 7 NHS regions in the development cohort. We validated the final models using data from an additional NHS region. Results: We found that major complications occurred in 4.4% (3037/68 599) of laparoscopic and 4.9% (6201/125 971) of abdominal hysterectomies. Our mo

United-kingdom
Sweden
Granada
Andalucísp
Spain
Bangladesh
United-states
Denmark
China
Finland
Canada
West-midlands

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.